Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Quantifying individual noxious-evoked baseline sensitivity to optimise analgesic trials in neonates.

Cobo MM. et al, (2021), Elife, 10

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.

Emary KRW. et al, (2021), Lancet, 397, 1351 - 1362

Functional and diffusion MRI reveal the neurophysiological basis of neonates’ noxious-stimulus evoked brain activity

BAXTER L. et al, (2021), Nature Communications

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.

Ogbe A. et al, (2021), Nat Commun, 12

How can community engagement in health research be strengthened for infectious disease outbreaks in Sub-Saharan Africa? A scoping review of the literature.

Vanderslott S. et al, (2021), BMC Public Health, 21

Using changes in brain activity to assess pain-relief in infants: Methodological considerations with Benoit et al. (2021).

Baxter L. et al, (2021), Early Hum Dev, 157

Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice.

Wang L. et al, (2021), Nat Genet

Identification of novel locus associated with coronary artery aneurysms and validation of loci for susceptibility to Kawasaki disease.

Hoggart C. et al, (2021), Eur J Hum Genet

RNA2HLA: HLA-based quality control of RNA-seq datasets

Chelysheva I. et al, (2021), Briefings in Bioinformatics

Functional and structural analysis of cytokine selective IL6ST defects that cause recessive hyper-IgE syndrome.

Chen Y-H. et al, (2021), J Allergy Clin Immunol

Therapeutic interventions for spinal muscular atrophy: preclinical and early clinical development opportunities.

Servais L. et al, (2021), Expert Opin Investig Drugs

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.

Madhi SA. et al, (2021), N Engl J Med

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.

Wouters OJ. et al, (2021), Lancet, 397, 1023 - 1034

An analysis of the potential global impact of dosing regimen and rollout options for the ChAdOx1 nCoV-19 vaccine

Aguas R. et al, (2021)

Risdiplam in Type 1 Spinal Muscular Atrophy.

Baranello G. et al, (2021), N Engl J Med, 384, 915 - 923

White matter hyperintensities classified according to intensity and spatial location reveal specific associations with cognitive performance

Melazzini L. et al, (2021), NeuroImage: Clinical

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.

Voysey M. et al, (2021), Lancet, 397, 881 - 891

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy.

Winkelsas AM. et al, (2021), Mol Ther Nucleic Acids, 23, 731 - 742

Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease: A Position Paper From the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition.

Uhlig HH. et al, (2021), J Pediatr Gastroenterol Nutr, 72, 456 - 473

Deciphering the transcriptomic heterogeneity of duodenal coeliac disease biopsies

Wolf J. et al, (2021), International Journal of Molecular Sciences, 22, 1 - 29

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?